Amphenol (APH) Financials

$85.70 -0.59 (-0.69%)

Closing price 05/21/2025 03:59 PM Eastern

Extended Trading

$85.74 +0.05 (+0.05%)

As of 05/21/2025 07:59 PM Eastern

Annual Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	2,424	1,928	1,902	1,580	1,203	1,155	1,205	651	823	764
Consolidated Net Income / (Loss)	2,442	1,946	1,917	1,591	1,213	1,164	1,217	661	833	772
Net Income / (Loss) Continuing Operations	2,442	1,946	1,917	1,580	1,213	1,164	1,217	661	833	772
Total Pre-Tax Income	3,012	2,455	2,467	1,989	1,527	1,496	1,588	1,352	1,141	1,053
Total Operating Income	3,157	2,560	2,586	2,105	1,638	1,619	1,687	1,428	1,205	1,105
Total Gross Profit	5,140	4,084	4,028	3,402	2,664	2,616	2,655	2,310	2,040	1,780
Total Revenue	15,223	12,555	12,623	10,876	8,599	8,225	8,202	7,011	6,286	5,569
Operating Revenue	15,223	12,555	12,623	10,876	8,599	8,225	8,202	7,011	6,286	5,569
Total Cost of Revenue	10,083	8,471	8,595	7,475	5,935	5,609	5,547	4,701	4,246	3,789
Operating Cost of Revenue	10,083	8,471	8,595	7,475	5,935	5,609	5,547	4,701	4,246	3,789
Total Operating Expenses	1,983	1,525	1,442	1,297	1,026	997	968	882	835	675
Selling, General & Admin Expense	1,855	1,490	1,421	1,226	1,014	971	960	878	798	669
Other Operating Expenses / (Income)	127	35	22	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-145	-105	-118	-116	-112	-123	-99	-75	-64	-52
Interest Expense	217	140	128	116	115	132	102	92	73	68
Other Income / (Expense), net	72	35	10	-0.40	3.60	8.60	3.20	17	8.50	16
Income Tax Expense	570	509	551	409	313	332	372	692	309	281
Net Income / (Loss) Attributable to Noncontrolling Interest	18	18	15	11	9.90	9.00	12	10	9.70	8.80
Basic Earnings per Share	$2.01	$1.62	$1.60	$2.66	$2.02	$1.94	$4.00	$2.13	$2.67	$2.47
Weighted Average Basic Shares Outstanding	1.20B	1.19B	1.19B	597.90M	596.10M	595M	301.20M	305.70M	308.30M	309.10M
Diluted Earnings per Share	$1.92	$1.55	$1.53	$2.54	$1.96	$1.88	$3.85	$2.06	$2.61	$2.41
Weighted Average Diluted Shares Outstanding	1.26B	1.24B	1.24B	625.50M	615M	615.90M	312.60M	316.50M	315.20M	316.50M
Weighted Average Basic & Diluted Shares Outstanding	1.21B	599.85M	594.60M	598.94M	299.58M	298.10M	301.30M	305.40M	308.20M	309.10M
Cash Dividends to Common per Share	$0.55	$0.43	$0.41	$0.64	$0.52	$0.48	$0.88	$0.70	$0.58	$0.53

This table shows Amphenol's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	738	746	604	525	549	514	514	461	439	508	497
Consolidated Net Income / (Loss)	744	752	609	529	552	519	518	465	443	511	501
Net Income / (Loss) Continuing Operations	744	752	609	529	552	519	518	465	443	511	501
Total Pre-Tax Income	963	910	775	664	663	666	634	596	560	633	651
Total Operating Income	1,025	954	820	699	685	690	658	620	592	666	681
Total Gross Profit	1,644	1,481	1,357	1,213	1,089	1,101	1,049	992	943	1,037	1,060
Total Revenue	4,811	4,318	4,039	3,610	3,256	3,328	3,199	3,054	2,974	3,239	3,295
Operating Revenue	4,811	4,318	4,039	3,610	3,256	3,328	3,199	3,054	2,974	3,239	3,295
Total Cost of Revenue	3,167	2,837	2,682	2,397	2,167	2,227	2,151	2,062	2,031	2,202	2,235
Operating Cost of Revenue	3,167	2,837	2,682	2,397	2,167	2,227	2,151	2,062	2,031	2,202	2,235
Total Operating Expenses	619	527	537	514	404	410	391	372	352	371	379
Selling, General & Admin Expense	575	515	492	444	404	394	382	368	346	362	367
Other Operating Expenses / (Income)	44	-	45	-	-	-	9.00	-	-	-	-
Total Other Income / (Expense), net	-62	-43	-45	-35	-22	-25	-24	-24	-32	-34	-30
Interest Expense	77	67	56	56	38	35	34	35	36	37	33
Other Income / (Expense), net	15	24	11	21	16	10	9.20	11	4.10	3.40	2.60
Income Tax Expense	219	158	166	135	111	146	115	131	117	122	150
Net Income / (Loss) Attributable to Noncontrolling Interest	6.40	5.90	4.50	3.90	3.30	4.80	4.40	4.80	3.50	3.50	3.90
Basic Earnings per Share	$0.61	$0.62	$0.50	$0.44	$0.91	$0.43	$0.43	$0.39	$0.74	$0.43	$0.83
Weighted Average Basic Shares Outstanding	1.21B	1.20B	1.20B	1.20B	600M	1.19B	1.20B	1.19B	595.10M	1.19B	595.30M
Diluted Earnings per Share	$0.58	$0.62	$0.48	$0.41	$0.87	$0.43	$0.41	$0.37	$0.71	$0.43	$0.80
Weighted Average Diluted Shares Outstanding	1.27B	1.26B	1.27B	1.26B	627.90M	1.24B	1.24B	1.24B	619.90M	1.24B	619.30M
Weighted Average Basic & Diluted Shares Outstanding	1.21B	1.21B	1.21B	1.20B	600.60M	599.85M	598.31M	596.45M	595.32M	594.60M	595.09M
Cash Dividends to Common per Share	$0.17	$0.18	$0.17	$0.11	$0.22	$0.12	-	$0.21	$0.21	$0.10	$0.20

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	1,842	102	176	-505	811	-388	-399	624	-703	768
Net Cash From Operating Activities	2,815	2,529	2,175	1,540	1,592	1,502	1,113	1,144	1,078	1,031
Net Cash From Continuing Operating Activities	2,815	2,529	2,175	1,524	1,592	1,502	1,113	1,144	1,078	1,031
Net Income / (Loss) Continuing Operations	2,442	1,946	1,917	1,580	1,213	1,164	1,217	661	833	772
Consolidated Net Income / (Loss)	2,442	1,946	1,917	1,580	-	1,164	1,217	661	833	772
Depreciation Expense	573	406	393	396	308	312	300	227	217	172
Non-Cash Adjustments To Reconcile Net Income	110	94	90	53	71	77	56	50	3.20	28
Changes in Operating Assets and Liabilities, net	-309	83	-225	-491	0.10	-51	-460	207	25	59
Net Cash From Investing Activities	-2,649	-1,394	-731	-1,888	-334	-1,229	-442	-380	-1,613	-27
Net Cash From Continuing Investing Activities	-2,649	-1,394	-731	-2,604	-334	-1,229	-442	-380	-1,613	-27
Purchase of Property, Plant & Equipment	-665	-373	-384	-360	-277	-295	-311	-227	-191	-172
Acquisitions	-2,156	-970	-288	-2,225	-50	-937	-159	-266	-1,305	-200
Purchase of Investments	-26	-306	-309	-165	-142	-65	-45	-40	-232	-135
Sale of Property, Plant & Equipment	7.80	4.00	5.60	3.70	13	7.40	5.00	4.10	7.10	8.70
Sale and/or Maturity of Investments	190	246	228	156	123	62	67	148	109	471
Other Investing Activities, net	1.90	4.90	17	-14	-0.60	0.00	0.00	-	-	-
Net Cash From Financing Activities	1,730	-1,012	-1,197	-145	-517	-648	-1,070	-140	-134	-180
Net Cash From Continuing Financing Activities	1,730	-1,012	-1,197	-145	-517	-648	-1,070	-140	-134	-180
Repayment of Debt	-391	-651	-215	-126	-2,367	-1,140	-565	-380	180	-218
Repurchase of Common Equity	-689	-585	-731	-662	-641	-602	-935	-618	-326	-249
Payment of Dividends	-628	-525	-487	-366	-313	-323	-272	-229	-180	-165
Issuance of Debt	2,991	355	51	752	2,510	1,170	572	903	0.00	371
Other Financing Activities, net	447	393	185	256	295	246	131	184	192	81
Other Net Changes in Cash	-54	-	-	-12	-	-13	-	-	-34	-
Cash Interest Paid	180	129	124	112	105	117	94	84	69	64
Cash Income Taxes Paid	650	560	478	446	337	408	393	325	247	251

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1,660	1,754	311	-605	382	-6.50	156	-66	18	184	-26
Net Cash From Operating Activities	765	847	704	664	600	842	618	536	532	705	576
Net Cash From Continuing Operating Activities	765	847	704	664	600	842	612	543	532	705	576
Net Income / (Loss) Continuing Operations	744	752	609	529	552	519	518	465	443	511	501
Consolidated Net Income / (Loss)	744	752	609	529	552	519	518	465	443	511	501
Depreciation Expense	236	144	201	124	104	115	101	94	96	108	103
Non-Cash Adjustments To Reconcile Net Income	27	30	30	27	24	27	32	13	22	25	24
Changes in Operating Assets and Liabilities, net	-242	-78	-136	-15	-80	181	-40	-29	-28	61	-51
Net Cash From Investing Activities	-2,353	-250	-203	-2,179	-17	-689	-329	-119	-257	-81	-273
Net Cash From Continuing Investing Activities	-2,353	-250	-203	-2,179	-17	-689	-329	-119	-257	-81	-273
Purchase of Property, Plant & Equipment	-189	-200	-230	-141	-94	-105	-75	-95	-98	-94	-121
Acquisitions	-2,172	-57	-	-2,100	0.00	-678	-179	-	-113	-	-214
Purchase of Investments	-3.10	-5.50	-7.30	-1.50	-12	-87	-80	-83	-57	-4.80	-101
Sale of Property, Plant & Equipment	4.10	0.70	1.70	4.90	0.50	1.90	0.50	0.80	0.80	1.10	1.70
Sale and/or Maturity of Investments	7.20	8.00	36	58	88	179	4.00	54	10	7.60	153
Other Investing Activities, net	0.00	2.80	-2.80	0.80	1.10	-	-0.10	4.80	0.20	9.10	7.90
Net Cash From Financing Activities	-89	1,214	-228	920	-176	-190	-118	-439	-265	-495	-263
Net Cash From Continuing Financing Activities	-89	1,214	-228	920	-176	-190	-118	-439	-265	-495	-263
Repayment of Debt	239	-24	-1.30	-362	-4.00	-5.40	-636	384	-393	-274	-46
Repurchase of Common Equity	-181	-169	-176	-190	-154	-115	-149	-154	-167	-170	-170
Payment of Dividends	-200	-211	-136	-150	-132	-142	-127	-126	-130	-125	-120
Issuance of Debt	0.00	1,491	-	1,500	0.00	0.90	635	-631	350	2.90	1.20
Other Financing Activities, net	53	127	86	121	113	71	159	89	74	71	72
Effect of Exchange Rate Changes	17	-	37	-9.60	-24	31	-	-	7.60	-	-
Cash Interest Paid	52	67	41	38	33	40	29	25	35	37	33
Cash Income Taxes Paid	168	134	157	229	130	137	99	208	116	90	140

This table presents Amphenol's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	21,440	16,526	15,326	14,678	12,327	10,816	10,045	10,004	8,499	7,458
Total Current Assets	9,686	6,835	6,479	5,958	5,491	4,211	4,572	4,656	3,591	3,850
Cash & Equivalents	3,317	1,475	1,373	1,197	1,702	891	1,279	1,719	1,035	1,737
Short-Term Investments	18	185	61	44	36	17	12	35	139	23
Accounts Receivable	3,288	2,618	2,631	2,455	1,952	1,736	1,792	1,599	1,349	1,105
Inventories, net	2,546	2,167	2,094	1,894	1,462	1,310	1,234	1,107	929	852
Prepaid Expenses	517	390	320	368	339	256	254	-	-	-
Plant, Property, & Equipment, net	1,712	1,315	1,204	1,175	1,055	999	876	817	711	610
Total Noncurrent Assets	10,042	8,376	7,643	7,545	5,782	5,605	4,598	4,531	4,196	2,999
Goodwill	8,236	7,092	6,446	6,377	5,032	4,867	4,103	4,043	3,679	2,693
Intangible Assets	1,225	835	734	757	398	442	398	489	517	306
Other Noncurrent Operating Assets	581	449	463	411	352	296	96	-	-	-
Total Liabilities & Shareholders' Equity	21,440	16,526	15,326	14,678	12,327	10,816	10,045	10,004	8,499	7,458
Total Liabilities	11,584	8,100	8,232	8,299	6,875	6,219	5,981	5,961	4,776	4,180
Total Current Liabilities	4,084	3,153	2,676	2,447	2,304	2,133	2,451	1,579	1,635	1,008
Short-Term Debt	402	354	2.70	4.00	230	403	764	1.10	375	0.30
Accounts Payable	1,819	1,351	1,309	1,312	1,121	867	891	876	678	588
Dividends Payable	200	132	125	120	87	74	69	58	49	43
Current Deferred & Payable Income Tax Liabilities	199	166	170	89	113	128	204	154	125	82
Current Employee Benefit Liabilities	530	413	417	366	291	172	157	152	132	106
Other Current Liabilities	934	738	653	556	463	489	367	339	276	190
Total Noncurrent Liabilities	7,500	4,947	5,556	5,852	4,571	4,087	3,529	4,381	3,140	3,172
Long-Term Debt	6,484	3,984	4,575	4,796	3,636	3,203	2,806	3,542	2,636	2,813
Noncurrent Deferred & Payable Income Tax Liabilities	377	367	410	424	299	260	256	241	78	-
Noncurrent Employee Benefit Liabilities	130	143	128	193	229	199	190	272	288	263
Other Noncurrent Operating Liabilities	509	454	443	439	407	424	277	326	139	96
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	8.70	31	21	19	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	9,847	8,396	7,074	6,360	5,452	4,596	4,064	4,043	3,723	3,278
Total Preferred & Common Equity	9,792	8,347	7,016	6,302	5,385	4,530	4,017	3,990	3,675	3,239
Total Common Equity	9,792	8,347	7,016	6,302	5,385	4,530	4,017	3,990	3,675	3,239
Common Stock	3,603	3,102	2,651	2,410	2,069	1,684	1,434	1,249	1,021	784
Retained Earnings	7,105	5,921	4,979	4,279	3,705	3,348	3,029	2,942	3,123	2,804
Treasury Stock	-200	-143	-80	-100	-111	-	-55	0.00	-	-
Accumulated Other Comprehensive Income / (Loss)	-716	-534	-535	-287	-278	-431	-390	-201	-469	-350
Noncontrolling Interest	55	49	58	58	67	66	47	54	48	40

This table presents Amphenol's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	22,902	21,440	19,586	18,587	16,723	16,526	15,759	15,238	15,382	15,326	15,098
Total Current Assets	9,133	9,686	7,773	6,972	7,042	6,835	6,773	6,321	6,394	6,479	6,327
Cash & Equivalents	1,657	3,317	1,563	1,253	1,857	1,475	1,482	1,325	1,391	1,373	1,189
Short-Term Investments	15	18	20	50	106	185	253	178	108	61	63
Accounts Receivable	3,920	3,288	3,130	2,856	2,501	2,618	2,571	2,444	2,412	2,631	2,640
Inventories, net	2,906	2,546	2,579	2,399	2,153	2,167	2,099	1,998	2,105	2,094	2,080
Prepaid Expenses	635	517	480	415	424	390	369	377	378	320	355
Plant, Property, & Equipment, net	1,855	1,712	1,671	1,534	1,312	1,315	1,247	1,259	1,244	1,204	1,167
Total Noncurrent Assets	11,914	10,042	10,142	10,081	8,369	8,376	7,739	7,658	7,744	7,643	7,604
Goodwill	9,274	8,236	8,352	8,262	7,101	7,092	6,575	6,519	6,540	6,446	6,338
Intangible Assets	2,002	1,225	1,247	1,309	785	835	744	724	743	734	754
Other Noncurrent Operating Assets	638	581	543	511	483	449	420	416	461	463	513
Total Liabilities & Shareholders' Equity	22,902	21,440	19,586	18,587	16,723	16,526	15,759	15,238	15,382	15,326	15,098
Total Liabilities	12,530	11,584	10,059	9,536	7,958	8,100	7,821	7,646	7,995	8,232	8,449
Total Current Liabilities	4,591	4,084	3,902	3,456	3,423	3,153	2,909	2,710	2,426	2,676	2,655
Short-Term Debt	351	402	403	404	753	354	356	352	2.90	2.70	2.90
Accounts Payable	2,142	1,819	1,763	1,521	1,265	1,351	1,249	1,117	1,182	1,309	1,394
Dividends Payable	200	200	199	132	132	132	126	125	125	125	119
Current Deferred & Payable Income Tax Liabilities	260	199	124	104	151	166	114	100	145	170	125
Current Employee Benefit Liabilities	475	530	480	423	351	413	361	336	306	417	369
Other Current Liabilities	1,163	934	932	870	772	738	704	680	666	653	646
Total Noncurrent Liabilities	7,939	7,500	6,157	6,081	4,535	4,947	4,912	4,936	5,569	5,556	5,794
Long-Term Debt	6,816	6,484	5,081	5,035	3,557	3,984	3,936	3,967	4,561	4,575	4,750
Noncurrent Deferred & Payable Income Tax Liabilities	387	377	440	446	371	367	413	407	412	410	442
Noncurrent Employee Benefit Liabilities	134	130	147	141	142	143	129	133	132	128	165
Other Noncurrent Operating Liabilities	602	509	489	458	465	454	433	428	464	443	436
Redeemable Noncontrolling Interest	9.30	8.70	21	20	31	31	22	21	21	21	20
Total Equity & Noncontrolling Interests	10,363	9,847	9,506	9,031	8,734	8,396	7,917	7,571	7,366	7,074	6,629
Total Preferred & Common Equity	10,301	9,792	9,453	8,980	8,682	8,347	7,857	7,514	7,308	7,016	6,571
Total Common Equity	10,301	9,792	9,453	8,980	8,682	8,347	7,857	7,514	7,308	7,016	6,571
Common Stock	3,673	3,603	3,459	3,350	3,225	3,102	3,016	2,861	2,749	2,651	2,566
Retained Earnings	7,446	7,105	6,751	6,352	6,164	5,921	5,670	5,295	5,121	4,979	4,775
Treasury Stock	-174	-200	-237	-74	-104	-143	-171	-50	-70	-80	-98
Accumulated Other Comprehensive Income / (Loss)	-644	-716	-520	-649	-603	-534	-658	-593	-493	-535	-672
Noncontrolling Interest	62	55	54	51	52	49	60	57	58	58	58

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.25%	-0.54%	16.06%	26.48%	4.54%	0.29%	16.98%	11.53%	12.89%	4.18%
EBITDA Growth	26.68%	0.40%	19.53%	28.21%	0.53%	-2.51%	19.04%	16.83%	10.68%	5.87%
EBIT Growth	24.46%	-0.06%	23.33%	28.18%	0.87%	-3.69%	16.99%	19.03%	8.26%	6.48%
NOPAT Growth	26.16%	0.98%	20.13%	28.42%	3.35%	-2.51%	85.30%	-20.69%	8.51%	6.51%
Net Income Growth	25.50%	1.50%	20.49%	31.11%	4.24%	-4.35%	84.18%	-20.65%	7.81%	7.98%
EPS Growth	23.87%	1.50%	20.49%	29.59%	4.24%	-4.35%	86.89%	-21.07%	8.30%	9.05%
Operating Cash Flow Growth	11.31%	16.28%	41.20%	-3.26%	5.97%	35.01%	-2.75%	6.18%	4.57%	12.87%
Free Cash Flow Firm Growth	-83.72%	-32.16%	337.24%	-171.54%	231.12%	-60.67%	84.89%	217.17%	-148.16%	165.43%
Invested Capital Growth	21.10%	8.42%	3.03%	31.18%	4.05%	14.92%	8.85%	5.00%	28.24%	1.66%
Revenue Q/Q Growth	6.96%	0.71%	1.71%	5.85%	3.30%	-0.89%	3.54%	4.36%	3.64%	0.07%
EBITDA Q/Q Growth	8.74%	1.27%	2.18%	5.72%	3.78%	-2.80%	5.39%	4.08%	4.35%	0.18%
EBIT Q/Q Growth	9.38%	1.21%	3.04%	5.21%	3.64%	-1.65%	3.35%	4.39%	4.28%	0.80%
NOPAT Q/Q Growth	10.81%	0.01%	2.92%	6.29%	3.13%	-1.49%	57.12%	-33.75%	4.39%	0.81%
Net Income Q/Q Growth	11.42%	1.18%	2.84%	6.56%	3.34%	-1.71%	56.98%	-33.90%	4.49%	1.02%
EPS Q/Q Growth	6.67%	1.18%	2.84%	2.42%	3.34%	-1.71%	51.57%	-36.42%	2.35%	-1.63%
Operating Cash Flow Q/Q Growth	0.19%	5.71%	12.10%	1.96%	1.07%	3.15%	-4.27%	7.41%	2.53%	7.35%
Free Cash Flow Firm Q/Q Growth	127.07%	-31.02%	97.32%	-945.22%	3.35%	-22.82%	10.18%	-26.60%	17.44%	5.45%
Invested Capital Q/Q Growth	-0.15%	5.77%	0.91%	9.55%	1.70%	1.67%	0.80%	-5.58%	-2.50%	-2.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.76%	32.53%	31.91%	31.28%	30.98%	31.80%	32.37%	32.95%	32.45%	31.96%
EBITDA Margin	24.97%	23.90%	23.68%	22.99%	22.68%	23.58%	24.26%	23.84%	22.76%	23.21%
Operating Margin	20.74%	20.39%	20.48%	19.35%	19.05%	19.69%	20.57%	20.36%	19.17%	19.84%
EBIT Margin	21.21%	20.66%	20.56%	19.35%	19.10%	19.79%	20.61%	20.61%	19.31%	20.13%
Profit (Net Income) Margin	16.04%	15.50%	15.19%	14.63%	14.11%	14.15%	14.84%	9.42%	13.24%	13.87%
Tax Burden Percent	81.07%	79.25%	77.69%	79.97%	79.48%	77.81%	76.61%	48.85%	72.96%	73.36%
Interest Burden Percent	93.28%	94.62%	95.05%	94.51%	92.97%	91.90%	93.98%	93.61%	94.02%	93.91%
Effective Tax Rate	18.93%	20.75%	22.32%	20.57%	20.52%	22.19%	23.39%	51.15%	27.04%	26.64%
Return on Invested Capital (ROIC)	20.60%	18.78%	19.67%	18.87%	17.32%	18.29%	21.01%	12.13%	17.61%	18.68%
ROIC Less NNEP Spread (ROIC-NNEP)	17.02%	16.05%	17.03%	16.11%	13.76%	14.54%	17.41%	10.16%	14.48%	15.58%
Return on Net Nonoperating Assets (RNNOA)	6.11%	6.29%	8.78%	8.02%	6.83%	8.60%	9.01%	4.89%	6.17%	6.17%
Return on Equity (ROE)	26.71%	25.07%	28.45%	26.89%	24.15%	26.88%	30.02%	17.01%	23.78%	24.85%
Cash Return on Invested Capital (CROIC)	1.51%	10.70%	16.69%	-8.10%	13.35%	4.40%	12.53%	7.25%	-7.13%	17.03%
Operating Return on Assets (OROA)	17.01%	16.29%	17.30%	15.59%	14.19%	15.61%	16.86%	15.62%	15.21%	15.52%
Return on Assets (ROA)	12.86%	12.22%	12.78%	11.78%	10.49%	11.16%	12.14%	7.14%	10.44%	10.69%
Return on Common Equity (ROCE)	26.50%	24.81%	28.12%	26.56%	23.83%	26.53%	29.65%	16.79%	23.48%	24.57%
Return on Equity Simple (ROE_SIMPLE)	24.93%	23.31%	27.32%	25.24%	22.53%	25.69%	30.29%	16.56%	22.66%	23.85%
Net Operating Profit after Tax (NOPAT)	2,559	2,029	2,009	1,672	1,302	1,260	1,292	697	879	810
NOPAT Margin	16.81%	16.16%	15.91%	15.37%	15.14%	15.32%	15.76%	9.95%	13.99%	14.55%
Net Nonoperating Expense Percent (NNEP)	3.58%	2.73%	2.65%	2.76%	3.56%	3.75%	3.60%	1.97%	3.14%	3.09%
Return On Investment Capital (ROIC_SIMPLE)	15.29%	15.93%	17.24%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	66.24%	67.47%	68.09%	68.72%	69.02%	68.20%	67.63%	67.05%	67.55%	68.04%
SG&A Expenses to Revenue	12.19%	11.87%	11.26%	11.28%	11.79%	11.81%	11.70%	12.53%	12.70%	12.02%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.03%	12.14%	11.43%	11.92%	11.93%	12.12%	11.80%	12.58%	13.28%	12.12%
Earnings before Interest and Taxes (EBIT)	3,229	2,594	2,596	2,105	1,642	1,628	1,690	1,445	1,214	1,121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,801	3,001	2,989	2,500	1,950	1,940	1,990	1,672	1,431	1,293
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.55	7.05	6.34	8.10	7.02	6.78	5.76	6.31	5.25	4.58
Price to Tangible Book Value (P/TBV)	253.19	140.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	61.92
Price to Revenue (P/Rev)	5.50	4.68	3.52	4.69	4.40	3.73	2.82	3.59	3.07	2.66
Price to Earnings (P/E)	34.54	30.51	23.38	32.29	31.43	26.59	19.20	38.67	23.43	19.43
Dividend Yield	0.79%	0.86%	1.08%	0.74%	0.82%	0.93%	1.15%	0.85%	0.93%	1.10%
Earnings Yield	2.90%	3.28%	4.28%	3.10%	3.18%	3.76%	5.21%	2.59%	4.27%	5.15%
Enterprise Value to Invested Capital (EV/IC)	6.42	5.48	4.60	5.43	5.22	4.54	3.97	4.58	3.77	3.64
Enterprise Value to Revenue (EV/Rev)	5.74	4.90	3.78	5.03	4.65	4.07	3.10	3.85	3.37	2.86
Enterprise Value to EBITDA (EV/EBITDA)	22.98	20.52	15.96	21.86	20.52	17.25	12.79	16.15	14.80	12.32
Enterprise Value to EBIT (EV/EBIT)	27.05	23.73	18.38	25.97	24.37	20.56	15.06	18.69	17.44	14.21
Enterprise Value to NOPAT (EV/NOPAT)	34.13	30.35	23.75	32.69	30.73	26.57	19.70	38.71	24.07	19.66
Enterprise Value to Operating Cash Flow (EV/OCF)	31.03	24.35	21.94	35.49	25.14	22.28	22.88	23.60	19.64	15.46
Enterprise Value to Free Cash Flow (EV/FCFF)	464.24	53.27	28.00	0.00	39.87	110.41	33.03	64.76	0.00	21.56
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.70	0.51	0.65	0.75	0.71	0.78	0.88	0.88	0.81	0.86
Long-Term Debt to Equity	0.66	0.47	0.64	0.75	0.67	0.70	0.69	0.88	0.71	0.86
Financial Leverage	0.36	0.39	0.52	0.50	0.50	0.59	0.52	0.48	0.43	0.40
Leverage Ratio	2.08	2.05	2.23	2.28	2.30	2.41	2.47	2.38	2.28	2.32
Compound Leverage Factor	1.94	1.94	2.12	2.16	2.14	2.21	2.32	2.23	2.14	2.18
Debt to Total Capital	41.13%	33.98%	39.22%	42.94%	41.49%	43.97%	46.77%	46.70%	44.71%	46.18%
Short-Term Debt to Total Capital	2.40%	2.77%	0.02%	0.04%	2.47%	4.92%	10.01%	0.01%	5.57%	0.00%
Long-Term Debt to Total Capital	38.73%	31.21%	39.20%	42.90%	39.02%	39.05%	36.76%	46.68%	39.14%	46.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.38%	0.63%	0.67%	0.69%	0.72%	0.80%	0.62%	0.71%	0.72%	0.66%
Common Equity to Total Capital	58.49%	65.39%	60.11%	56.37%	57.79%	55.23%	52.61%	52.59%	54.57%	53.16%
Debt to EBITDA	1.81	1.45	1.53	1.92	1.98	1.86	1.79	2.12	2.10	2.18
Net Debt to EBITDA	0.93	0.89	1.05	1.42	1.09	1.39	1.15	1.07	1.28	0.81
Long-Term Debt to EBITDA	1.71	1.33	1.53	1.92	1.86	1.65	1.41	2.12	1.84	2.18
Debt to NOPAT	2.69	2.14	2.28	2.87	2.97	2.86	2.76	5.08	3.42	3.47
Net Debt to NOPAT	1.39	1.32	1.56	2.13	1.63	2.14	1.76	2.57	2.09	1.30
Long-Term Debt to NOPAT	2.53	1.96	2.28	2.87	2.79	2.54	2.17	5.08	3.00	3.47
Altman Z-Score	6.32	6.40	5.38	5.60	5.17	4.88	4.37	4.49	4.42	4.36
Noncontrolling Interest Sharing Ratio	0.79%	1.02%	1.15%	1.22%	1.32%	1.31%	1.24%	1.31%	1.26%	1.13%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.37	2.17	2.42	2.43	2.38	1.97	1.87	2.95	2.20	3.82
Quick Ratio	1.62	1.36	1.52	1.51	1.60	1.24	1.26	2.12	1.54	2.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	188	1,156	1,704	-718	1,004	303	771	417	-356	739
Operating Cash Flow to CapEx	428.03%	685.66%	574.99%	431.76%	602.80%	522.36%	364.10%	514.25%	586.61%	630.66%
Free Cash Flow to Firm to Interest Expense	0.87	8.29	13.27	-6.22	8.70	2.30	7.58	4.52	-4.90	10.82
Operating Cash Flow to Interest Expense	12.97	18.13	16.94	13.33	13.80	11.39	10.94	12.40	14.84	15.09
Operating Cash Flow Less CapEx to Interest Expense	9.94	15.48	13.99	10.25	11.51	9.21	7.94	9.99	12.31	12.70
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.80	0.79	0.84	0.81	0.74	0.79	0.82	0.76	0.79	0.77
Accounts Receivable Turnover	5.15	4.78	4.96	4.94	4.66	4.66	4.84	4.76	5.12	5.00
Inventory Turnover	4.28	3.98	4.31	4.45	4.28	4.41	4.74	4.62	4.77	4.41
Fixed Asset Turnover	10.06	9.97	10.61	9.76	8.37	8.77	9.69	9.18	9.52	9.28
Accounts Payable Turnover	6.36	6.37	6.56	6.15	5.97	6.38	6.28	6.05	6.71	6.28
Days Sales Outstanding (DSO)	70.81	76.31	73.53	73.94	78.27	78.28	75.44	76.73	71.24	73.03
Days Inventory Outstanding (DIO)	85.30	91.80	84.67	81.95	85.25	82.77	77.01	79.03	76.53	82.72
Days Payable Outstanding (DPO)	57.38	57.31	55.66	59.40	61.12	57.17	58.10	60.32	54.41	58.09
Cash Conversion Cycle (CCC)	98.73	110.80	102.55	96.49	102.41	103.87	94.34	95.44	93.36	97.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	13,606	11,235	10,363	10,057	7,667	7,369	6,412	5,890	5,610	4,375
Invested Capital Turnover	1.23	1.16	1.24	1.23	1.14	1.19	1.33	1.22	1.26	1.28
Increase / (Decrease) in Invested Capital	2,371	873	305	2,390	298	957	522	281	1,235	72
Enterprise Value (EV)	87,345	61,571	47,707	54,655	40,021	33,470	25,459	27,000	21,168	15,929
Market Capitalization	83,730	58,814	44,485	51,019	37,826	30,706	23,132	25,157	19,282	14,836
Book Value per Share	$8.12	$13.95	$11.79	$10.54	$18.00	$15.28	$13.33	$13.07	$11.91	$10.51
Tangible Book Value per Share	$0.27	$0.70	($0.28)	($1.39)	($0.15)	($2.63)	($1.61)	($1.77)	($1.69)	$0.78
Total Capital	16,742	12,764	11,672	11,179	9,318	8,203	7,635	7,586	6,734	6,092
Total Debt	6,886	4,337	4,578	4,800	3,867	3,607	3,571	3,543	3,011	2,814
Total Long-Term Debt	6,484	3,984	4,575	4,796	3,636	3,203	2,806	3,542	2,636	2,813
Net Debt	3,551	2,677	3,144	3,559	2,128	2,698	2,279	1,789	1,838	1,053
Capital Expenditures (CapEx)	658	369	378	357	264	288	306	223	184	163
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,669	2,376	2,372	2,274	1,679	1,573	1,593	1,324	1,158	1,082
Debt-free Net Working Capital (DFNWC)	6,004	4,036	3,806	3,515	3,417	2,482	2,885	3,078	2,331	2,842
Net Working Capital (NWC)	5,602	3,683	3,803	3,511	3,187	2,079	2,120	3,077	1,956	2,842
Net Nonoperating Expense (NNE)	118	83	92	81	89	96	75	37	47	38
Net Nonoperating Obligations (NNO)	3,750	2,809	3,268	3,678	2,215	2,773	2,348	1,847	1,887	1,096
Total Depreciation and Amortization (D&A)	573	406	393	396	308	312	300	227	217	172
Debt-free, Cash-free Net Working Capital to Revenue	17.53%	18.93%	18.79%	20.91%	19.52%	19.13%	19.42%	18.88%	18.42%	19.42%
Debt-free Net Working Capital to Revenue	39.44%	32.15%	30.15%	32.32%	39.74%	30.17%	35.17%	43.90%	37.08%	51.03%
Net Working Capital to Revenue	36.80%	29.33%	30.13%	32.28%	37.06%	25.27%	25.85%	43.88%	31.11%	51.03%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.01	$1.62	$1.60	$1.33	$1.01	$0.97	$0.00	$0.00	$0.00	$0.62
Adjusted Weighted Average Basic Shares Outstanding	1.20B	1.19B	1.19B	1.20B	1.19B	1.19B	0.00	0.00	0.00	1.24B
Adjusted Diluted Earnings per Share	$1.92	$1.56	$1.53	$1.27	$0.98	$0.94	$0.00	$0.00	$0.00	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	1.26B	1.24B	1.24B	1.25B	1.23B	1.23B	0.00	0.00	0.00	1.27B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.21B	1.20B	1.19B	1.20B	1.20B	1.19B	0.00	0.00	0.00	1.23B
Normalized Net Operating Profit after Tax (NOPAT)	2,559	2,029	2,009	1,728	1,311	1,280	1,299	1,002	906	815
Normalized NOPAT Margin	16.81%	16.16%	15.91%	15.89%	15.25%	15.56%	15.84%	14.29%	14.41%	14.63%
Pre Tax Income Margin	19.79%	19.55%	19.55%	18.29%	17.75%	18.19%	19.37%	19.29%	18.15%	18.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.88	18.60	20.22	18.22	14.23	12.34	16.62	15.65	16.72	16.41
NOPAT to Interest Expense	11.79	14.54	15.64	14.48	11.28	9.55	12.71	7.56	12.11	11.86
EBIT Less CapEx to Interest Expense	11.85	15.95	17.27	15.13	11.94	10.16	13.61	13.24	14.19	14.02
NOPAT Less CapEx to Interest Expense	8.76	11.90	12.70	11.39	9.00	7.37	9.70	5.15	9.58	9.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	25.72%	26.96%	25.42%	22.98%	25.76%	27.73%	22.34%	34.72%	21.56%	21.42%
Augmented Payout Ratio	53.96%	57.04%	63.53%	64.58%	78.61%	79.42%	99.19%	128.26%	60.69%	53.65%

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	47.74%	29.76%	26.24%	18.20%	9.49%	2.73%	-2.91%	-2.64%	0.75%	7.01%	16.91%
EBITDA Growth	58.55%	37.47%	34.36%	16.37%	16.25%	4.85%	-2.31%	-2.29%	1.39%	8.95%	17.99%
EBIT Growth	48.32%	39.51%	24.52%	14.14%	17.62%	4.63%	-2.43%	-3.10%	0.73%	12.94%	19.70%
NOPAT Growth	38.86%	46.33%	19.62%	14.99%	21.92%	0.05%	2.78%	-2.75%	4.12%	11.87%	17.89%
Net Income Growth	34.82%	44.84%	17.48%	13.63%	24.69%	1.60%	3.56%	-2.27%	3.15%	11.57%	16.56%
EPS Growth	31.82%	44.19%	17.07%	10.81%	22.54%	1.60%	3.56%	-2.27%	4.41%	11.57%	17.65%
Operating Cash Flow Growth	27.59%	0.63%	13.90%	23.81%	12.60%	19.35%	7.31%	-1.12%	51.77%	49.87%	59.65%
Free Cash Flow Firm Growth	-4,122.94%	-373.42%	-1,372.89%	-1,700.35%	-164.94%	-243.49%	132.85%	121.73%	107.65%	112.21%	52.86%
Invested Capital Growth	42.91%	21.10%	28.29%	26.45%	6.30%	8.42%	3.44%	3.38%	3.13%	3.03%	11.85%
Revenue Q/Q Growth	11.42%	6.91%	11.89%	10.85%	-2.14%	4.01%	4.76%	2.69%	-8.18%	-1.70%	5.05%
EBITDA Q/Q Growth	13.79%	8.63%	22.32%	4.86%	-1.34%	6.17%	5.94%	4.75%	-11.02%	-1.08%	5.97%
EBIT Q/Q Growth	6.35%	17.65%	15.36%	2.75%	0.04%	5.01%	5.74%	5.89%	-11.01%	-2.08%	5.01%
NOPAT Q/Q Growth	0.53%	22.36%	15.68%	-2.42%	5.95%	0.02%	11.20%	3.46%	-13.06%	2.75%	5.22%
Net Income Q/Q Growth	-1.04%	23.50%	15.17%	-4.22%	10.03%	0.17%	11.39%	5.11%	-10.84%	2.10%	5.13%
EPS Q/Q Growth	-6.45%	29.17%	17.07%	-52.87%	4.82%	0.17%	11.39%	5.11%	-14.46%	2.10%	5.26%
Operating Cash Flow Q/Q Growth	-9.70%	20.33%	6.01%	10.78%	-28.78%	36.19%	15.23%	0.75%	-24.51%	22.45%	6.18%
Free Cash Flow Firm Q/Q Growth	-154.72%	32.94%	-5.87%	-2,235.20%	71.44%	-280.31%	33.10%	-5.24%	-36.90%	141.28%	11.97%
Invested Capital Q/Q Growth	18.09%	-0.15%	2.30%	18.48%	0.07%	5.77%	0.84%	-0.41%	2.07%	0.91%	0.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.17%	34.29%	33.60%	33.61%	33.44%	33.07%	32.77%	32.47%	31.72%	32.03%	32.17%
EBITDA Margin	26.52%	25.96%	25.55%	23.37%	24.71%	24.51%	24.01%	23.74%	23.27%	24.01%	23.86%
Operating Margin	21.30%	22.09%	20.29%	19.36%	21.03%	20.74%	20.56%	20.30%	19.90%	20.56%	20.67%
EBIT Margin	21.60%	22.63%	20.57%	19.95%	21.52%	21.05%	20.85%	20.66%	20.03%	20.67%	20.75%
Profit (Net Income) Margin	15.47%	17.42%	15.08%	14.65%	16.95%	15.60%	16.20%	15.24%	14.89%	15.78%	15.19%
Tax Burden Percent	77.29%	82.60%	78.57%	79.65%	83.30%	78.02%	81.82%	78.08%	79.07%	80.79%	76.89%
Interest Burden Percent	92.64%	93.15%	93.29%	92.18%	94.56%	95.00%	94.96%	94.45%	93.97%	94.47%	95.20%
Effective Tax Rate	22.71%	17.40%	21.43%	20.35%	16.70%	21.98%	18.18%	21.92%	20.93%	19.21%	23.11%
Return on Invested Capital (ROIC)	20.23%	22.36%	18.71%	17.31%	20.61%	18.81%	20.08%	19.22%	19.10%	20.54%	20.28%
ROIC Less NNEP Spread (ROIC-NNEP)	19.06%	21.27%	17.68%	16.54%	19.96%	18.18%	19.45%	18.65%	18.37%	19.76%	19.60%
Return on Net Nonoperating Assets (RNNOA)	8.14%	7.63%	6.87%	7.17%	7.01%	7.12%	8.40%	8.69%	9.18%	10.19%	10.52%
Return on Equity (ROE)	28.37%	29.99%	25.58%	24.48%	27.62%	25.93%	28.48%	27.91%	28.28%	30.73%	30.80%
Cash Return on Invested Capital (CROIC)	-14.97%	1.51%	-5.73%	-4.89%	13.43%	10.70%	16.04%	16.11%	16.38%	16.69%	8.88%
Operating Return on Assets (OROA)	18.30%	18.15%	16.56%	15.80%	17.21%	16.59%	16.85%	17.17%	16.75%	17.39%	17.15%
Return on Assets (ROA)	13.10%	13.97%	12.14%	11.60%	13.56%	12.30%	13.09%	12.67%	12.44%	13.27%	12.56%
Return on Common Equity (ROCE)	28.14%	29.76%	25.35%	24.26%	27.34%	25.66%	28.17%	27.60%	27.96%	30.37%	30.46%
Return on Equity Simple (ROE_SIMPLE)	25.57%	0.00%	23.18%	23.39%	23.47%	0.00%	24.47%	25.35%	26.21%	0.00%	28.36%
Net Operating Profit after Tax (NOPAT)	792	788	644	557	570	538	538	484	468	538	524
NOPAT Margin	16.46%	18.25%	15.94%	15.42%	17.52%	16.18%	16.82%	15.85%	15.73%	16.61%	15.89%
Net Nonoperating Expense Percent (NNEP)	1.17%	1.09%	1.03%	0.77%	0.65%	0.63%	0.63%	0.57%	0.72%	0.78%	0.68%
Return On Investment Capital (ROIC_SIMPLE)	4.52%	4.71%	-	-	-	4.23%	-	-	-	4.62%	-
Cost of Revenue to Revenue	65.83%	65.71%	66.40%	66.39%	66.56%	66.93%	67.23%	67.53%	68.28%	67.97%	67.83%
SG&A Expenses to Revenue	11.96%	11.92%	12.18%	12.31%	12.41%	11.85%	11.93%	12.04%	11.64%	11.17%	11.13%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.87%	12.20%	13.31%	14.25%	12.41%	12.33%	12.21%	12.17%	11.83%	11.46%	11.50%
Earnings before Interest and Taxes (EBIT)	1,039	977	831	720	701	701	667	631	596	670	684
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,276	1,121	1,032	844	805	816	768	725	692	778	786
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.71	8.55	8.30	9.01	7.94	7.05	6.32	6.68	6.58	6.34	5.96
Price to Tangible Book Value (P/TBV)	0.00	253.19	0.00	0.00	86.61	140.27	92.32	184.67	1,899.88	0.00	0.00
Price to Revenue (P/Rev)	4.73	5.50	5.51	6.04	5.37	4.68	3.98	3.99	3.80	3.52	3.16
Price to Earnings (P/E)	30.40	34.54	36.08	38.83	34.11	30.51	26.05	26.55	25.28	23.38	21.19
Dividend Yield	0.92%	0.79%	0.76%	0.65%	0.75%	0.86%	1.01%	0.99%	1.01%	1.08%	1.21%
Earnings Yield	3.29%	2.90%	2.77%	2.58%	2.93%	3.28%	3.84%	3.77%	3.96%	4.28%	4.72%
Enterprise Value to Invested Capital (EV/IC)	5.29	6.42	6.05	6.39	6.35	5.48	4.93	5.04	4.84	4.60	4.16
Enterprise Value to Revenue (EV/Rev)	5.07	5.74	5.79	6.36	5.56	4.90	4.20	4.22	4.05	3.78	3.45
Enterprise Value to EBITDA (EV/EBITDA)	19.90	22.98	23.58	26.34	22.91	20.52	17.66	17.79	17.08	15.96	14.62
Enterprise Value to EBIT (EV/EBIT)	23.83	27.05	27.93	30.53	26.43	23.73	20.41	20.56	19.70	18.38	16.98
Enterprise Value to NOPAT (EV/NOPAT)	30.57	34.13	35.70	38.63	33.47	30.35	25.79	26.35	25.26	23.75	21.91
Enterprise Value to Operating Cash Flow (EV/OCF)	28.52	31.03	29.35	31.26	27.48	24.35	21.87	22.57	21.73	21.94	22.05
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	464.24	0.00	0.00	48.68	53.27	31.22	31.79	30.01	28.00	49.53
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.69	0.70	0.58	0.60	0.49	0.51	0.54	0.57	0.62	0.65	0.71
Long-Term Debt to Equity	0.66	0.66	0.53	0.56	0.41	0.47	0.50	0.52	0.62	0.64	0.71
Financial Leverage	0.43	0.36	0.39	0.43	0.35	0.39	0.43	0.47	0.50	0.52	0.54
Leverage Ratio	2.07	2.08	2.02	2.03	1.99	2.05	2.12	2.14	2.18	2.23	2.37
Compound Leverage Factor	1.92	1.93	1.89	1.87	1.88	1.95	2.01	2.02	2.05	2.10	2.26
Debt to Total Capital	40.86%	41.13%	36.53%	37.54%	32.96%	33.98%	35.09%	36.26%	38.19%	39.22%	41.69%
Short-Term Debt to Total Capital	2.00%	2.40%	2.69%	2.79%	5.76%	2.77%	2.91%	2.95%	0.02%	0.02%	0.03%
Long-Term Debt to Total Capital	38.86%	38.73%	33.85%	34.75%	27.21%	31.21%	32.19%	33.31%	38.17%	39.20%	41.66%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.41%	0.38%	0.50%	0.49%	0.64%	0.63%	0.67%	0.66%	0.66%	0.67%	0.68%
Common Equity to Total Capital	58.73%	58.49%	62.97%	61.97%	66.40%	65.39%	64.24%	63.08%	61.15%	60.11%	57.63%
Debt to EBITDA	1.68	1.81	1.57	1.68	1.38	1.45	1.45	1.45	1.52	1.53	1.63
Net Debt to EBITDA	1.29	0.93	1.12	1.28	0.75	0.89	0.86	0.94	1.02	1.05	1.20
Long-Term Debt to EBITDA	1.60	1.71	1.45	1.56	1.14	1.33	1.33	1.33	1.52	1.53	1.62
Debt to NOPAT	2.58	2.69	2.37	2.47	2.02	2.14	2.12	2.15	2.25	2.28	2.44
Net Debt to NOPAT	1.98	1.39	1.69	1.88	1.10	1.32	1.26	1.40	1.51	1.56	1.79
Long-Term Debt to NOPAT	2.45	2.53	2.20	2.28	1.67	1.96	1.94	1.97	2.25	2.28	2.43
Altman Z-Score	5.38	5.97	6.27	6.65	6.88	6.03	5.54	5.67	5.33	4.96	4.49
Noncontrolling Interest Sharing Ratio	0.81%	0.79%	0.89%	0.90%	1.00%	1.02%	1.09%	1.11%	1.12%	1.15%	1.11%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.99	2.37	1.99	2.02	2.06	2.17	2.33	2.33	2.64	2.42	2.38
Quick Ratio	1.22	1.62	1.21	1.20	1.30	1.36	1.48	1.46	1.61	1.52	1.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,033	-1,583	-2,361	-2,230	-95	-334	185	139	147	233	-565
Operating Cash Flow to CapEx	414.58%	425.46%	308.37%	486.88%	639.13%	816.49%	833.02%	567.02%	549.43%	762.49%	482.82%
Free Cash Flow to Firm to Interest Expense	-52.71	-23.66	-42.38	-39.61	-2.51	-9.55	5.52	3.98	4.10	6.30	-17.21
Operating Cash Flow to Interest Expense	10.00	12.66	12.64	11.80	15.73	24.05	18.40	15.33	14.83	19.06	17.56
Operating Cash Flow Less CapEx to Interest Expense	7.59	9.69	8.54	9.37	13.27	21.11	16.19	12.62	12.13	16.56	13.92
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.80	0.81	0.79	0.80	0.79	0.81	0.83	0.84	0.84	0.83
Accounts Receivable Turnover	5.23	5.15	4.99	5.05	5.23	4.78	4.78	5.01	5.23	4.96	5.12
Inventory Turnover	4.38	4.28	4.05	4.07	4.04	3.98	4.04	4.22	4.20	4.31	4.21
Fixed Asset Turnover	10.60	10.06	9.76	9.59	10.05	9.97	10.33	10.41	10.46	10.61	10.60
Accounts Payable Turnover	6.51	6.36	6.29	6.78	7.04	6.37	6.39	6.85	7.00	6.56	6.30
Days Sales Outstanding (DSO)	69.85	70.81	73.11	72.21	69.85	76.31	76.29	72.86	69.77	73.53	71.24
Days Inventory Outstanding (DIO)	83.31	85.30	90.12	89.73	90.28	91.80	90.31	86.47	86.89	84.67	86.80
Days Payable Outstanding (DPO)	56.11	57.38	58.03	53.85	51.88	57.31	57.10	53.27	52.16	55.66	57.98
Cash Conversion Cycle (CCC)	97.06	98.73	105.21	108.10	108.25	110.80	109.50	106.06	104.50	102.55	100.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	16,067	13,606	13,627	13,320	11,243	11,235	10,622	10,534	10,577	10,363	10,269
Invested Capital Turnover	1.23	1.23	1.17	1.12	1.18	1.16	1.19	1.21	1.21	1.24	1.28
Increase / (Decrease) in Invested Capital	4,825	2,371	3,005	2,787	666	873	353	345	321	305	1,088
Enterprise Value (EV)	85,001	87,345	82,447	85,133	71,334	61,571	52,315	53,050	51,210	47,707	42,765
Market Capitalization	79,435	83,730	78,471	80,925	68,905	58,814	49,675	50,155	48,067	44,485	39,186
Book Value per Share	$8.51	$8.12	$7.85	$14.95	$14.47	$13.95	$13.17	$12.62	$12.29	$11.79	$11.05
Tangible Book Value per Share	($0.80)	$0.27	($0.12)	($0.98)	$1.33	$0.70	$0.90	$0.46	$0.04	($0.28)	($0.87)
Total Capital	17,539	16,742	15,011	14,490	13,074	12,764	12,230	11,912	11,950	11,672	11,402
Total Debt	7,167	6,886	5,484	5,439	4,309	4,337	4,292	4,319	4,564	4,578	4,753
Total Long-Term Debt	6,816	6,484	5,081	5,035	3,557	3,984	3,936	3,967	4,561	4,575	4,750
Net Debt	5,495	3,551	3,901	4,137	2,346	2,677	2,558	2,816	3,065	3,144	3,501
Capital Expenditures (CapEx)	185	199	228	136	94	103	74	95	97	93	119
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,221	2,669	2,691	2,618	2,408	2,376	2,486	2,460	2,472	2,372	2,423
Debt-free Net Working Capital (DFNWC)	4,893	6,004	4,274	3,920	4,371	4,036	4,220	3,963	3,971	3,806	3,675
Net Working Capital (NWC)	4,542	5,602	3,871	3,516	3,619	3,683	3,865	3,612	3,968	3,803	3,672
Net Nonoperating Expense (NNE)	48	36	35	28	18	19	20	19	25	27	23
Net Nonoperating Obligations (NNO)	5,695	3,750	4,100	4,270	2,478	2,809	2,684	2,941	3,190	3,268	3,620
Total Depreciation and Amortization (D&A)	236	144	201	124	104	115	101	94	96	108	103
Debt-free, Cash-free Net Working Capital to Revenue	19.20%	17.53%	18.91%	19.55%	18.76%	18.93%	19.94%	19.59%	19.55%	18.79%	19.52%
Debt-free Net Working Capital to Revenue	29.16%	39.44%	30.03%	29.27%	34.05%	32.15%	33.85%	31.55%	31.40%	30.15%	29.61%
Net Working Capital to Revenue	27.07%	36.80%	27.20%	26.25%	28.19%	29.33%	31.00%	28.75%	31.38%	30.13%	29.59%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.61	$0.62	$0.50	$0.44	$0.46	$0.22	$0.43	$0.39	$0.37	$0.22	$0.42
Adjusted Weighted Average Basic Shares Outstanding	1.21B	1.20B	1.20B	1.20B	1.20B	2.39B	1.20B	1.19B	1.19B	2.38B	1.19B
Adjusted Diluted Earnings per Share	$0.58	$0.62	$0.48	$0.41	$0.44	$0.22	$0.42	$0.37	$0.36	$0.22	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	1.27B	1.26B	1.27B	1.26B	1.26B	2.48B	1.24B	1.24B	1.24B	2.48B	1.24B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.62	$0.00	$0.00	$0.00	$0.22	$0.00	$0.00	$0.00	$0.22	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.21B	1.21B	1.21B	1.20B	1.20B	1.20B	1.20B	1.19B	1.19B	1.19B	1.19B
Normalized Net Operating Profit after Tax (NOPAT)	792	788	644	612	570	538	538	487	472	538	533
Normalized NOPAT Margin	16.46%	18.25%	15.94%	16.96%	17.52%	16.18%	16.82%	15.95%	15.87%	16.61%	16.17%
Pre Tax Income Margin	20.01%	21.08%	19.19%	18.39%	20.35%	20.00%	19.80%	19.51%	18.83%	19.53%	19.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.59	14.61	14.91	12.79	18.39	20.01	19.85	18.03	16.60	18.09	20.84
NOPAT to Interest Expense	10.35	11.78	11.56	9.89	14.97	15.38	16.02	13.83	13.03	14.54	15.97
EBIT Less CapEx to Interest Expense	11.18	11.63	10.82	10.37	15.93	17.07	17.65	15.32	13.90	15.59	17.21
NOPAT Less CapEx to Interest Expense	7.94	8.80	7.46	7.46	12.51	12.44	13.81	11.13	10.33	12.04	12.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.42%	25.72%	25.49%	26.16%	25.83%	26.96%	26.39%	26.27%	25.79%	25.42%	24.53%
Augmented Payout Ratio	53.62%	53.96%	54.50%	55.14%	53.90%	57.04%	59.69%	60.97%	61.98%	63.53%	63.74%

Frequently Asked Questions About Amphenol's Financials

When does Amphenol's fiscal year end?

According to the most recent income statement we have on file, Amphenol's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Amphenol's net income changed over the last 9 years?

Amphenol's net income appears to be on an upward trend, with a most recent value of $2.44 billion in 2024, rising from $772.30 million in 2015. The previous period was $1.95 billion in 2023. See Amphenol's forecast for analyst expectations on what’s next for the company.

What is Amphenol's operating income?

Amphenol's total operating income in 2024 was $3.16 billion, based on the following breakdown:

Total Gross Profit: $5.14 billion
Total Operating Expenses: $1.98 billion

How has Amphenol revenue changed over the last 9 years?

Over the last 9 years, Amphenol's total revenue changed from $5.57 billion in 2015 to $15.22 billion in 2024, a change of 173.4%.

How much debt does Amphenol have?

Amphenol's total liabilities were at $11.58 billion at the end of 2024, a 43.0% increase from 2023, and a 177.1% increase since 2015.

How much cash does Amphenol have?

In the past 9 years, Amphenol's cash and equivalents has ranged from $891.20 million in 2019 to $3.32 billion in 2024, and is currently $3.32 billion as of their latest financial filing in 2024.

How has Amphenol's book value per share changed over the last 9 years?

Over the last 9 years, Amphenol's book value per share changed from 10.51 in 2015 to 8.12 in 2024, a change of -22.7%.

Related Companies

This page (NYSE:APH) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amphenol (APH) Financials

Frequently Asked Questions About Amphenol's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amphenol (APH) Financials

Annual Income Statements for Amphenol

Quarterly Income Statements for Amphenol

Annual Cash Flow Statements for Amphenol

Quarterly Cash Flow Statements for Amphenol

Annual Balance Sheets for Amphenol

Quarterly Balance Sheets for Amphenol

Annual Metrics And Ratios for Amphenol

Quarterly Metrics And Ratios for Amphenol

Frequently Asked Questions About Amphenol's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools